Propanc Biopharma Correlations

Propanc Biopharma Market Linkage

Propanc Biopharma has a market cap of 1.88 M. See Your Equity Center for portfolio-level analysis. Propanc Biopharma Common can be included in a portfolio to evaluate diversification impact. This information is provided for contextual purposes. Broader economic conditions can influence Propanc Biopharma Common's company valuation — related indicators include signals in discontinued.

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations SRBCF + 1.0 QPTFF HOOK + 0.87 CLCS SYGGF + 0.47 GLABF ZHCLF + 0.36 CLCS HOOK + 0.33 ZHCLF IMUC + 0.29 TELIF

High negative correlations CLCS - 0.63 GLABF HOOK - 0.53 GLABF SYGGF - 0.44 PRVCF SYGGF - 0.43 TELIF ZHCLF - 0.4 GLABF HOOK - 0.38 PRVCF

Risk-Adjusted Indicators

Propanc Biopharma Company can look attractive on recent price action while risk efficiency lags the peer group. Reviewing Propanc Biopharma's risk-adjusted indicators gives a clearer view of whether returns are being earned efficiently. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.